Effect of Wenxin Granule combined metoprolol on atrial fibrillation: a meta-analysis

Mingming Zhao,Hairong Wang,Feng Xiong,Chen Nie,You Zhou
DOI: https://doi.org/10.3760/cma.j.issn.1673-4777.2014.04.003
2014-01-01
Abstract:Objective To evaluate the efficacy and safety of Wenxin Granule and metoprolol for atrial fibrillation.Methods We searched The Cochrane Library(2013 December),Pubmed(the commencement of the database to 2013),EMBASE (the commencement of the database to 2013),China Nation Knowledge infrastructure (the commencement of the database to 2013) and the Wanfang Data base(the commencement of the database to 2013),Weipu Data base(the commencement of the database to 2013),CBM (the commencement of the database to 2013)on computers for parallel group randomized controlled trials (RCTs) comparing Wenxin Granule combined metoprolol and metoprolol for patients with atrial fibrallation.Three researchers selected the trials based on the include and exclude criterions and then extracted the data including sample size,basic information of patients,intervening measure,course of treatment,clinical efficacy,adverse effect,and so on.Assessed the quality of each trial using the tool for assessing risk of bias recommended by eochrane collaboration independently.After cross checked,The RevMan 5.1 software provided by the cochrane collaboration was used to perform meta-analysis.Results Eleven RCTs were involved.All trial methodologies are low quality.A total of 805 patients.Four twenty two patients were treated using Wenxin Granule combined metoprolol as the treatment group.383 patients were treated using metoprolol as the control group.There were 265 cases whose symptoms and onset of atrial fibrillation were improved in the treatment group and 185 cases in the control group.25 eases in the treatment group happened adverse effect and 26 cases in the control group.Meta-analysis showed that:Wenxin Granule combined metoprolol had better curative effect on atrial fibrillation than metoprolol:symptom-improvement [relative risk (RR) =1.34,95% confidenceinterval(CI):1.17-1.54],reduced the onset of atrial fibrillation (RR =1.31,95% CI:1.15-1.48),symptom-improvement also reduce the onset of atrial fibrillation (RR =1.23,95% CI:1.14-1.34).But there was not significant difference in adverse effects rate between the two groups (RR =1.00,95% CI:0.59-1.69,P > 0.05).Conclusions Compaired to metoprolol,Wenxin Granule combined metoprolol has better curative effect.The adverse effect rate between two groups is not significantly different.But because of little-scale,inferior quality,biase risk of these trials,large-scale,rational design and multicenter RCTS are needed to confirm our conlusions.
What problem does this paper attempt to address?